AstraZeneca vaccine temporarily suspended as precautionary measure over reports of blood clots

Administration of the Astrazeneca vaccine has been temporarily suspended by the HSE on advice from the National Immunisation Advisory Committee (NIAC) this morning. This comes following NIAC receiving “new information” from the Norwegian Medicines Agency yesterday of four reports of “serious blood clotting events in adults after vaccination with Covid-19 Vaccine AstraZeneca”. In a statement from Deputy Chief Medical Officer Dr Ronan Glynn, he confirms the decision was taken in light of this new evidence and following discussions with the Health Products Regulatory Authority (HPRA).